Enhabit [EHAB] vs Surgery Partners [SGRY] Detailed Stock Comparison

Enhabit Inc.

NYSE
Loading...

Surgery Partners Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Enhabit Inc. wins in 9 metrics, Surgery Partners Inc. wins in 10 metrics, with 0 ties. Surgery Partners Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Enhabit Inc. Surgery Partners Inc. Better
P/E Ratio (TTM) N/A 2,956.00 N/A
Price-to-Book Ratio 1.30 1.09 Surgery Partners Inc.
Debt-to-Equity Ratio 88.64 114.51 Enhabit Inc.
PEG Ratio 22.11 -34.35 Enhabit Inc.
EV/EBITDA 13.71 11.42 Surgery Partners Inc.
Profit Margin (TTM) -0.43% -2.35% Enhabit Inc.
Operating Margin (TTM) 5.33% 15.09% Surgery Partners Inc.
EBITDA Margin (TTM) 5.33% 15.09% Surgery Partners Inc.
Return on Equity -0.47% 2.76% Surgery Partners Inc.
Return on Assets (TTM) 3.33% 3.74% Surgery Partners Inc.
Free Cash Flow (TTM) $65.80M $195.60M Surgery Partners Inc.
1-Year Return 29.70% -32.67% Enhabit Inc.
Price-to-Sales Ratio (TTM) 0.66 0.57 Surgery Partners Inc.
Enterprise Value $1.18B $7.49B Surgery Partners Inc.
EV/Revenue Ratio 1.12 2.26 Enhabit Inc.
Gross Profit Margin (TTM) 48.71% 23.98% Enhabit Inc.
Revenue per Share (TTM) $21 $26 Surgery Partners Inc.
Earnings per Share (Diluted) $-0.09 $-0.61 Enhabit Inc.
Beta (Stock Volatility) 1.08 1.99 Enhabit Inc.
Short % of Float 2.74% 22.70% Enhabit Inc.

Enhabit Inc. vs Surgery Partners Inc. Stock Performance Analysis

Loading Price Chart...

EHAB
SGRY

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Enhabit Inc.0.07%0.22%-1.00%22.23%70.58%51.82%
Surgery Partners Inc.-1.18%9.24%8.46%22.11%-2.01%-0.85%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Enhabit Inc.29.70%16.06%-44.80%-44.80%-44.80%-44.80%
Surgery Partners Inc.-32.67%-62.68%-76.34%-2.17%-16.93%-16.93%

Performance & Financial Health Analysis: Enhabit Inc. vs Surgery Partners Inc.

MetricEHABSGRY
Market Information
Market Cap i$703.84M$1.86B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i871,239864,264
90 Day Avg. Volume i1,167,9501,150,188
Last Close$13.80$15.13
52 Week Range$6.47 - $14.22$11.41 - $24.10
% from 52W High-2.95%-37.22%
All-Time High$25.25 (Jun 20, 2022)$69.58 (Jun 21, 2021)
% from All-Time High-45.35%-78.26%
Growth Metrics
Quarterly Revenue Growth0.05%0.02%
Quarterly Earnings Growth0.05%0.02%
Financial Health
Profit Margin (TTM) i0.00%-0.02%
Operating Margin (TTM) i0.05%0.15%
Return on Equity (TTM) i0.00%0.03%
Debt to Equity (MRQ) i88.64114.51
Cash & Liquidity
Book Value per Share (MRQ)$10.53$13.37
Cash per Share (MRQ)$0.86$1.87
Operating Cash Flow (TTM) i$70.70M$274.30M
Levered Free Cash Flow (TTM) i$57.23M$164.71M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Enhabit Inc. vs Surgery Partners Inc.

MetricEHAB (Apr 23, 2026)SGRY (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) iN/A2,956.00
Forward P/E i22.1137.68
PEG Ratio i22.11-34.35
Price to Sales (TTM) i0.660.57
Price to Book (MRQ) i1.301.09
Market Capitalization
Market Capitalization i$703.84M$1.86B
Enterprise Value i$1.18B$7.49B
Enterprise Value Metrics
Enterprise to Revenue i1.122.26
Enterprise to EBITDA i13.7111.42
Risk & Other Metrics
Beta i1.081.99
Book Value per Share (MRQ) i$10.53$13.37

Financial Statements Comparison: Enhabit Inc. vs Surgery Partners Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEHAB (2025)SGRY (2025)
Revenue/Sales i1.06B3.31B
Cost of Goods Sold i540.20M2.54B
COGS % of Revenue i51.0%76.9%
Gross Profit i519.80M765.00M
Gross Margin i49.0%23.1%
Research & Development iN/AN/A
Operating Income (EBIT) i63.80M470.80M
Operating Margin i6.0%14.2%
EBITDA i105.60M678.40M
EBITDA Margin i10.0%20.5%
Pre-Tax Income i1.40M116.90M
Pre-Tax Income % of Revenue i0.1%3.5%
Income Tax i4.00M18.00M
Income Tax % of Revenue i0.4%0.5%
Net Income (Profit) i-2.60M98.90M
Profit Margin i-0.2%3.0%

Balance Sheet & Liquidity Metrics

MetricEHAB (2025)SGRY (2025)
Cash & Equivalents i43.60M239.90M
Total Current Assets i205.60M1.15B
Total Current Assets % of Revenue i19.4%34.8%
Total Current Liabilities i126.30M615.50M
Total Current Liabilities % of Revenue i11.9%18.6%
Long-Term Debt i465.10M3.88B
Long-Term Debt % of Revenue i43.9%117.4%
Total Shareholders Equity i564.10M3.53B
Retained Earnings i93.70M-815.20M
Retained Earnings % of Revenue i8.8%-24.6%
Property, Plant & Equipment i49.80M1.60B

Cash Flow Statement Comparison

MetricEHAB (2025)SGRY (2025)
Operating Cash Flow i40.80M243.40M
Operating Cash Flow % of Revenue i3.8%7.4%
Capital Expenditures i-4.90M-32.20M
Free Cash Flow i65.80M195.60M
FCF Margin i6.2%5.9%
Debt Repayment i-67.70M-1.04B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricEHABSGRY
Shares Short i1.35M14.00M
Short Ratio i0.897.57
Short % of Float i2.74%22.70%
Shares Outstanding i50.72M129.32M
Float Shares i44.11M55.54M
% Held by Insiders i3.61%1.53%
% Held by Institutions i88.49%122.23%
% Held by Public i7.90%-23.76%

Dividend Analysis & Yield Comparison: Enhabit Inc. vs Surgery Partners Inc.

MetricEHABSGRY
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A